Tag: Wild-type transthyretin amyloid

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Wild-type transthyretin amyloid

New machine-learning model can identify individuals at risk of rare cardiomyopathy ...

Added to Collection on: 2021-10-26 07:18:20

Tags for this article:

Branches of biology
Anatomy
Amyloidosis
Proteins
Cardiomyopathy
Histopathology
Wild-type transthyretin amyloid
Protein folding
Transthyretin
Amyloid cardiomyopathy
Carpal tunnel syndrome
Electronic health record
Sanjiv Shah

Click the tags to see associated articles and topics

View Article Details
Tafamidis confers 5-year survival benefit in transthyretin amyloid cardiomyopathy - Healio

Added to Collection on: 2021-12-28 18:02:19

Tags for this article:

Branches of biology
Amyloidosis
Organ systems
Proteins
Neurological disorders
Breakthrough therapy
Tafamidis
Familial amyloid polyneuropathy
Transthyretin
Wild-type transthyretin amyloid
Amyloid cardiomyopathy
Pfizer
Perry Elliott

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody

Added to Collection on: 2022-03-01 22:43:08

Tags for this article:

Branches of biology
Amyloidosis
Proteins
Transthyretin
Amyloid
Protein folding
Familial amyloid cardiomyopathy
Wild-type transthyretin amyloid

Click the tags to see associated articles and topics

View Article Details
Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based ...

Added to Collection on: 2022-06-25 16:11:19

Tags for this article:

Branches of biology
Amyloidosis
Biology
Proteins
Neurological disorders
Familial amyloid polyneuropathy
Protein folding
Intellia Therapeutics
Transthyretin
Wild-type transthyretin amyloid
CRISPR
I Intellia Therapeutics Inc.
REGENERON PHARMACEUTICALS , INC

Click the tags to see associated articles and topics

View Article Details
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early ...

Added to Collection on: 2024-01-15 20:28:13

Tags for this article:

Amyloidosis
Heart diseases
Protein folding
Cardiac amyloidosis
Heart failure
Echocardiography
Medical diagnosis
Wild-type transthyretin amyloid
Pfizer

Click the tags to see associated articles and topics

View Article Details
Intellia's CRISPR Therapy Shows 90%+ Disease Protein Reduction in Key Clinical Trial

Added to Collection on: 2024-11-17 02:14:16

Tags for this article:

Amyloidosis
Cardiomyopathy
Neurological disorders
Protein folding
Familial amyloid polyneuropathy
Familial amyloid cardiomyopathy
Intellia Therapeutics
Transthyretin
Brain natriuretic peptide 32
Heart failure
Acoramidis
Wild-type transthyretin amyloid
CRISPR

Click the tags to see associated articles and topics

View Article Details
New gene editing therapy 'safe and effective' - Royal Free London NHS Foundation Trust

Added to Collection on: 2024-11-16 15:46:38

Tags for this article:

Amyloidosis
Transthyretin
Intellia Therapeutics
Wild-type transthyretin amyloid
Therapy
Familial amyloid polyneuropathy

Click the tags to see associated articles and topics

View Article Details
Intellia Announces First Clinical Evidence from Ongoing - GlobeNewswire

Added to Collection on: 2024-11-16 15:31:31

Tags for this article:

Amyloidosis
Neurological disorders
Cardiomyopathy
Protein folding
Familial amyloid polyneuropathy
Familial amyloid cardiomyopathy
Transthyretin
Intellia Therapeutics
Troponin
Vutrisiran
Wild-type transthyretin amyloid
CRISPR

Click the tags to see associated articles and topics

View Article Details
New gene editing therapy for heart condition is safe and effective | UCL News

Added to Collection on: 2024-11-19 22:11:36

Tags for this article:

Amyloidosis
CRISPR gene editing
Familial amyloid polyneuropathy
Intellia Therapeutics
Transthyretin
Therapy
Wild-type transthyretin amyloid
Gene therapy

Click the tags to see associated articles and topics

View Article Details
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT ...

Added to Collection on: 2024-11-25 17:33:34

Tags for this article:

Amyloidosis
Neurological disorders
Pharmaceuticals policy
Intellia Therapeutics
Protein folding
Familial amyloid polyneuropathy
Transthyretin
Regenerative Medicine Advanced Therapy
Orphan drug
Wild-type transthyretin amyloid
Alnylam Pharmaceuticals
CRISPR
Intellia Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details